David Weinshenker Selected Research

David Weinshenker Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
11	Cognitive Dysfunction 11/2023 - 01/2013
9	Cocaine-Related Disorders (Cocaine Addiction) 01/2017 - 10/2006
9	Epilepsy (Aura) 01/2016 - 06/2002
7	Seizures (Absence Seizure) 02/2023 - 04/2006
6	Parkinson Disease (Parkinson's Disease) 03/2023 - 01/2016
5	Disease Progression 01/2020 - 11/2017
5	Substance-Related Disorders (Drug Abuse) 01/2019 - 10/2006
4	Neuroinflammatory Diseases 06/2023 - 01/2018
4	Schizophrenia (Dementia Praecox) 01/2019 - 03/2005
3	Pain (Aches) 03/2023 - 01/2002
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2024 - 01/2020
2	Opioid-Related Disorders (Opiate Addiction) 03/2023 - 10/2021
2	Status Epilepticus (Complex Partial Status Epilepticus) 02/2023 - 12/2012
2	Prodromal Symptoms 01/2023 - 01/2023
2	Dementia (Dementias) 01/2023 - 01/2016
2	Infections 01/2016 - 03/2010
2	Hypersensitivity (Allergy) 01/2016 - 10/2006
2	Memory Disorders (Memory Loss) 02/2014 - 01/2013
2	Alcoholism (Alcohol Abuse) 01/2012 - 08/2009
2	Psychotic Disorders (Schizoaffective Disorder) 09/2006 - 03/2005
1	Wounds and Injuries (Trauma) 07/2023
1	Obesity 06/2023
1	Neurobehavioral Manifestations 06/2023
1	Inflammation (Inflammations) 01/2022
1	Catalepsy 10/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Shock 01/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 07/2020
1	Gliosis 01/2020
1	Galactosemias (Galactosemia) 01/2020
1	Amyloid Plaque 10/2019
1	Tauopathies 01/2018
1	Gambling (Pathological Gambling) 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 10/2017

Drug/Important Bio-Agent (IBA)

22	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2024 - 01/2002
11	Dopamine (Intropin)FDA LinkGeneric 03/2023 - 01/2002
10	Amyloid (Amyloid Fibrils)IBA 06/2023 - 01/2013
9	Cocaine (Cocaine HCl)IBA 01/2017 - 10/2006
8	Disulfiram (Antabuse)FDA Link 01/2018 - 10/2006
8	Dopamine beta-HydroxylaseIBA 03/2010 - 01/2002
7	EnzymesIBA 01/2020 - 01/2002
5	Amyloid beta-PeptidesIBA 11/2023 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 06/2023 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2006
4	CatecholaminesIBA 01/2023 - 06/2002
4	Opioid Analgesics (Opioids)IBA 10/2021 - 01/2002
4	GalaninIBA 01/2021 - 10/2013
4	Antidepressive Agents (Antidepressants)IBA 10/2013 - 04/2006
3	Presenilin-1IBA 06/2023 - 06/2014
3	NeurotoxinsIBA 01/2023 - 10/2015
3	Morphine (MS Contin)FDA LinkGeneric 10/2021 - 01/2002
3	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016 - 11/2010
3	Anticonvulsants (Antiepileptic Drugs)IBA 10/2013 - 04/2006
3	Flurothyl (Flurotyl)IBA 07/2013 - 04/2006
3	Amphetamine (Amfetamine)FDA LinkGeneric 09/2006 - 10/2002
2	neuromelaninIBA 01/2024 - 01/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 07/2023 - 01/2016
2	Adrenergic Agents (Adrenergic Drugs)IBA 07/2023 - 01/2016
2	Kainic Acid (Kainate)IBA 02/2023 - 05/2007
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2023 - 01/2022
2	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 10/2015
2	SynucleinsIBA 01/2023 - 01/2020
2	DSP 4 (DSP-4)IBA 01/2023 - 01/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016 - 01/2002
2	Pilocarpine (Ocusert)FDA LinkGeneric 10/2013 - 12/2012
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 09/2006 - 03/2005
2	Ethanol (Ethyl Alcohol)IBA 09/2006 - 03/2005
2	Phencyclidine (Angel Dust)IBA 09/2006 - 03/2005
2	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 09/2006 - 03/2005
1	salicylhydroxamic acid (SHAM)IBA 07/2023
1	CholesterolIBA 06/2023
1	SugarsIBA 06/2023
1	Methadone (Dolophine)FDA LinkGeneric 03/2023
1	Opioid Receptors (Opioid Receptor)IBA 03/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2023
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022
1	AZD4694IBA 01/2022
1	OsteoprotegerinIBA 01/2022
1	CytokinesIBA 01/2022
1	N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA 10/2021
1	Apolipoprotein E4IBA 01/2021
1	Naloxone (Narcan)FDA LinkGeneric 01/2021
1	Type 1 Galanin ReceptorIBA 01/2021
1	NeuropeptidesIBA 01/2021
1	Apolipoprotein E3IBA 01/2021
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2020
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2020
1	galactose-1-phosphateIBA 01/2020
1	Serine (L-Serine)FDA Link 10/2019
1	serine racemaseIBA 10/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	Protein AggregatesIBA 10/2017
1	beta-Arrestin 1IBA 01/2017
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2016

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 01/2020 - 10/2006
5	Therapeutics 01/2023 - 12/2012
2	Analgesia 05/2009 - 01/2002
2	Ketogenic Diet 11/2008 - 03/2006